{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T15:11:36Z","timestamp":1791904296560,"version":"4.3.4"},"reference-count":100,"publisher":"The Endocrine Society","issue":"10","license":[{"start":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T00:00:00Z","timestamp":1597104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK091601"],"award-info":[{"award-number":["DK091601"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Nonalcoholic fatty liver disease (NAFLD) prevalence in women is increasing worldwide. Women of reproductive age have lower rates of NAFLD compared with men; however, this protection is lost following the menopausal transition when NAFLD prevalence in postmenopausal women becomes similar to or surpasses that in age-matched male counterparts. Ongoing epidemiological, clinical, and experimental studies indicate greater NAFLD risk and higher rates of severe hepatic fibrosis in postmenopausal women relative to premenopausal women, and that older women with NAFLD experience greater mortality than men. Investigations involving ovariectomized animal models demonstrate a causal relationship between estrogen deficiency and heightened susceptibility to the development of fatty liver and steatohepatitis, although dietary factors may exacerbate this complex relationship. The accumulated findings suggest that a better understanding of the interplay among menopausal status, metabolic comorbidities, and sex steroids in NAFLD pathogenesis is needed. Further, the mechanisms underlying the difference in NAFLD risk between postmenopausal and premenopausal women remain incompletely understood. The goals of this review are to summarize studies of NAFLD risk in postmenopausal women, discuss results from animal models of estrogen deficiency, and explore the development of NAFD within the context of altered sex hormone profiles resulting from the menopausal transition. Potential implications for the prevention, diagnosis, and treatment of NAFLD in this relatively understudied cohort are also addressed.<\/jats:p>","DOI":"10.1210\/endocr\/bqaa134","type":"journal-article","created":{"date-parts":[[2020,8,10]],"date-time":"2020-08-10T07:36:27Z","timestamp":1597044987000},"source":"Crossref","is-referenced-by-count":220,"title":["NAFLD and NASH in Postmenopausal Women: Implications for Diagnosis and Treatment"],"prefix":"10.1210","volume":"161","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3286-0270","authenticated-orcid":false,"given":"Johanna K","family":"DiStefano","sequence":"first","affiliation":[{"name":"Diabetes and Fibrotic Disease Research Unit, Translational Genomics Research Institute, Phoenix, Arizona"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2020,8,11]]},"reference":[{"issue":"1","key":"2021121718160162400_CIT0001","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol."},{"issue":"1","key":"2021121718160162400_CIT0002","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/hep.29466","article-title":"Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease","volume":"67","author":"Estes","year":"2018","journal-title":"Hepatology."},{"issue":"5","key":"2021121718160162400_CIT0003","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1002\/hep.28785","article-title":"The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology."},{"issue":"4","key":"2021121718160162400_CIT0004","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1002\/hep.30626","article-title":"Sex differences in nonalcoholic fatty liver disease: state of the art and identification of research gaps","volume":"70","author":"Lonardo","year":"2019","journal-title":"Hepatology."},{"issue":"1","key":"2021121718160162400_CIT0005","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/hep4.1285","article-title":"Prevalence of nonalcoholic fatty liver disease in the female population","volume":"3","author":"Arshad","year":"2019","journal-title":"Hepatol Commun."},{"issue":"11","key":"2021121718160162400_CIT0006","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1002\/hep4.1419","article-title":"Mortality related to nonalcoholic fatty liver disease is increasing in the United States","volume":"3","author":"Paik","year":"2019","journal-title":"Hepatol Commun."},{"issue":"11","key":"2021121718160162400_CIT0007","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1038\/s41395-018-0088-6","article-title":"NASH leading cause of liver transplant in women: updated analysis of indications for liver transplant and ethnic and gender variances","volume":"113","author":"Noureddin","year":"2018","journal-title":"Am J Gastroenterol."},{"issue":"6","key":"2021121718160162400_CIT0008","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/hep.25762","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association","volume":"55","author":"Chalasani","year":"2012","journal-title":"Hepatology."},{"issue":"18","key":"2021121718160162400_CIT0009","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1007\/s00018-018-2860-6","article-title":"Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease","volume":"75","author":"Ipsen","year":"2018","journal-title":"Cell Mol Life Sci."},{"issue":"12","key":"2021121718160162400_CIT0010","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1007\/BF01070758","article-title":"Fatty liver: biochemical and clinical considerations","volume":"20","author":"Hoyumpa","year":"1975","journal-title":"Am J Dig Dis."},{"issue":"6","key":"2021121718160162400_CIT0011","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology."},{"issue":"3","key":"2021121718160162400_CIT0012","doi-asserted-by":"crossref","first-page":"582","DOI":"10.2214\/AJR.11.6729","article-title":"MRI steatosis grading: development and initial validation of a color mapping system","volume":"198","author":"Qayyum","year":"2012","journal-title":"AJR Am J Roentgenol."},{"issue":"6","key":"2021121718160162400_CIT0013","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0016-5085(99)70506-8","article-title":"Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity","volume":"116","author":"Matteoni","year":"1999","journal-title":"Gastroenterology."},{"issue":"2","key":"2021121718160162400_CIT0014","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.cgh.2008.11.005","article-title":"Long-term follow-up of patients with nonalcoholic fatty liver","volume":"7","author":"Rafiq","year":"2009","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"9","key":"2021121718160162400_CIT0015","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1111\/j.1572-0241.1999.01377.x","article-title":"Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions","volume":"94","author":"Brunt","year":"1999","journal-title":"Am J Gastroenterol."},{"issue":"5","key":"2021121718160162400_CIT0016","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.jhep.2014.11.034","article-title":"Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management","volume":"62","author":"McPherson","year":"2015","journal-title":"J Hepatol."},{"issue":"1","key":"2021121718160162400_CIT0017","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1053\/j.gastro.2010.09.038","article-title":"Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study","volume":"140","author":"Williams","year":"2011","journal-title":"Gastroenterology."},{"issue":"9","key":"2021121718160162400_CIT0018","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.mayocp.2015.06.013","article-title":"Recommendations for diagnosis, referral for liver biopsy, and treatment of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"90","author":"Spengler","year":"2015","journal-title":"Mayo Clin Proc."},{"issue":"4","key":"2021121718160162400_CIT0019","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.cgh.2014.04.014","article-title":"Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies","volume":"13","author":"Singh","year":"2015","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"12","key":"2021121718160162400_CIT0020","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.cgh.2012.10.001","article-title":"Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review","volume":"10","author":"White","year":"2012","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"4","key":"2021121718160162400_CIT0021","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1053\/j.gastro.2011.06.061","article-title":"Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States","volume":"141","author":"Charlton","year":"2011","journal-title":"Gastroenterology."},{"issue":"6","key":"2021121718160162400_CIT0022","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.jhep.2016.07.033","article-title":"NAFLD and liver transplantation: Current burden and expected challenges","volume":"65","author":"Pais","year":"2016","journal-title":"J Hepatol."},{"issue":"6","key":"2021121718160162400_CIT0023","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.jhep.2017.07.027","article-title":"Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD","volume":"67","author":"Hagstr\u00f6m","year":"2017","journal-title":"J Hepatol."},{"issue":"6","key":"2021121718160162400_CIT0024","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1007\/s12325-017-0556-1","article-title":"NAFLD as a sexual dimorphic disease: role of gender and reproductive status in the development and progression of nonalcoholic fatty liver disease and inherent cardiovascular risk","volume":"34","author":"Ballestri","year":"2017","journal-title":"Adv Ther."},{"issue":"3","key":"2021121718160162400_CIT0025","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.jhep.2005.02.042","article-title":"Prevalence of and risk factors for fatty liver in a general population of Shanghai, China","volume":"43","author":"Fan","year":"2005","journal-title":"J Hepatol."},{"issue":"1 Pt 1","key":"2021121718160162400_CIT0026","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1440-1746.2005.04086.x","article-title":"Prevalence and risk factors of non-alcoholic fatty liver disease among Korean adults","volume":"21","author":"Park","year":"2006","journal-title":"J Gastroenterol Hepatol."},{"issue":"5","key":"2021121718160162400_CIT0027","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.3748\/wjg.v9.i5.1106","article-title":"Prevalence of nonalcoholic fatty liver among administrative officers in Shanghai: an epidemiological survey","volume":"9","author":"Shen","year":"2003","journal-title":"World J Gastroenterol."},{"issue":"9","key":"2021121718160162400_CIT0028","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1097\/MEG.0000000000000151","article-title":"Sex-specific prevalence of fatty liver disease and associated metabolic factors in Wuhan, south central China","volume":"26","author":"Wang","year":"2014","journal-title":"Eur J Gastroenterol Hepatol."},{"issue":"10","key":"2021121718160162400_CIT0029","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1111\/jgh.12290","article-title":"Epidemiological survey and risk factor analysis of fatty liver disease of adult residents, Beijing, China","volume":"28","author":"Yan","year":"2013","journal-title":"J Gastroenterol Hepatol."},{"issue":"47","key":"2021121718160162400_CIT0030","doi-asserted-by":"crossref","first-page":"6419","DOI":"10.3748\/wjg.v13.i47.6419","article-title":"Prevalence of fatty liver disease and its risk factors in the population of South China","volume":"13","author":"Zhou","year":"2007","journal-title":"World J Gastroenterol."},{"issue":"10","key":"2021121718160162400_CIT0031","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1007\/s00535-003-1178-8","article-title":"Increase in the prevalence of fatty liver in Japan over the past 12 years: analysis of clinical background","volume":"38","author":"Kojima","year":"2003","journal-title":"J Gastroenterol."},{"issue":"3","key":"2021121718160162400_CIT0032","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3748\/wjg.v18.i3.237","article-title":"Aging is a risk factor of nonalcoholic fatty liver disease in premenopausal women","volume":"18","author":"Hamaguchi","year":"2012","journal-title":"World J Gastroenterol."},{"issue":"14","key":"2021121718160162400_CIT0033","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1001\/archinte.168.14.1568","article-title":"Menopause and the metabolic syndrome: the Study of Women\u2019s Health Across the Nation","volume":"168","author":"Janssen","year":"2008","journal-title":"Arch Intern Med."},{"issue":"6","key":"2021121718160162400_CIT0034","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/ijo.2008.25","article-title":"Increased visceral fat and decreased energy expenditure during the menopausal transition","volume":"32","author":"Lovejoy","year":"2008","journal-title":"Int J Obes (Lond)."},{"issue":"2","key":"2021121718160162400_CIT0035","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/sj.ijo.0801118","article-title":"Effect of menopausal status on body composition and abdominal fat distribution","volume":"24","author":"Toth","year":"2000","journal-title":"Int J Obes Relat Metab Disord."},{"issue":"Suppl 1","key":"2021121718160162400_CIT0036","doi-asserted-by":"crossref","first-page":"16S","DOI":"10.1038\/oby.2006.277","article-title":"Why visceral fat is bad: mechanisms of the metabolic syndrome","volume":"14","author":"Bergman","year":"2006","journal-title":"Obesity (Silver Spring)."},{"key":"2021121718160162400_CIT0037","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2019\/2763093","article-title":"Association between serum uric acid and non-alcoholic fatty liver disease according to different menstrual status groups","volume":"2019","author":"Chen","year":"2019","journal-title":"Can J Gastroenterol Hepatol."},{"key":"2021121718160162400_CIT0038","first-page":"1","article-title":"The influence of metabolic factors for nonalcoholic Fatty liver disease in women","volume":"2015","author":"Chung","year":"2015","journal-title":"Biomed Res Int."},{"issue":"4","key":"2021121718160162400_CIT0039","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S1665-2681(19)31616-3","article-title":"Prevalence of non alcoholic fatty liver disease in premenopausal, posmenopausal and polycystic ovary syndrome women. The role of estrogens","volume":"9","author":"Gutierrez-Grobe","year":"2010","journal-title":"Ann Hepatol."},{"issue":"2","key":"2021121718160162400_CIT0040","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000346202","article-title":"Relationship between serum uric acid level and nonalcoholic fatty liver disease in pre- and postmenopausal women","volume":"62","author":"Moon","year":"2013","journal-title":"Ann Nutr Metab."},{"key":"2021121718160162400_CIT0041","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejogrb.2015.04.017","article-title":"Menopausal stages and non-alcoholic fatty liver disease in middle-aged women","volume":"190","author":"Ryu","year":"2015","journal-title":"Eur J Obstet Gynecol Reprod Biol."},{"issue":"1","key":"2021121718160162400_CIT0042","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12902-019-0427-7","article-title":"Prevalence of cardiovascular risk factors in non-menopausal and postmenopausal inpatients with type 2 diabetes mellitus in China","volume":"19","author":"Zhou","year":"2019","journal-title":"BMC Endocr Disord."},{"issue":"4","key":"2021121718160162400_CIT0043","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1136\/gut.2006.115345","article-title":"Menopausal status and hepatic steatosis in a general female population","volume":"56","author":"V\u00f6lzke","year":"2007","journal-title":"Gut."},{"issue":"12","key":"2021121718160162400_CIT0044","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.cgh.2010.08.005","article-title":"Regional anthropometric measures and hepatic fibrosis in patients with nonalcoholic fatty liver disease","volume":"8","author":"Suzuki","year":"2010","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"4","key":"2021121718160162400_CIT0045","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1002\/hep.26761","article-title":"Gender and menopause impact severity of fibrosis among patients with nonalcoholic steatohepatitis","volume":"59","author":"Yang","year":"2014","journal-title":"Hepatology."},{"issue":"5","key":"2021121718160162400_CIT0046","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1002\/hep.27097","article-title":"The influence of menopause on the development of hepatic fibrosis in nonobese women with nonalcoholic fatty liver disease","volume":"60","author":"Yoneda","year":"2014","journal-title":"Hepatology."},{"issue":"9","key":"2021121718160162400_CIT0047","first-page":"1037","article-title":"Ovarian senescence increases liver fibrosis in humans and zebrafish with steatosis","volume":"8","author":"Turola","year":"2015","journal-title":"Dis Model Mech."},{"issue":"1","key":"2021121718160162400_CIT0048","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/hep.28514","article-title":"A longer duration of estrogen deficiency increases fibrosis risk among postmenopausal women with nonalcoholic fatty liver disease","volume":"64","author":"Klair","year":"2016","journal-title":"Hepatology."},{"issue":"12","key":"2021121718160162400_CIT0049","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1172\/JCI9575","article-title":"Altered expression of fatty acid-metabolizing enzymes in aromatase-deficient mice","volume":"105","author":"Nemoto","year":"2000","journal-title":"J Clin Invest."},{"issue":"6","key":"2021121718160162400_CIT0050","doi-asserted-by":"crossref","first-page":"594","DOI":"10.3109\/13697137.2011.637650","article-title":"Liver fat accumulation may be dissociated from adiposity gain in ovariectomized rats","volume":"15","author":"C\u00f4t\u00e9","year":"2012","journal-title":"Climacteric."},{"issue":"2","key":"2021121718160162400_CIT0051","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.maturitas.2007.08.002","article-title":"Time course of liver lipid infiltration in ovariectomized rats: impact of a high-fat diet","volume":"58","author":"Paquette","year":"2007","journal-title":"Maturitas."},{"issue":"5","key":"2021121718160162400_CIT0052","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1210\/en.2008-1405","article-title":"Reduced energy expenditure and increased inflammation are early events in the development of ovariectomy-induced obesity","volume":"150","author":"Rogers","year":"2009","journal-title":"Endocrinology."},{"issue":"6","key":"2021121718160162400_CIT0053","doi-asserted-by":"crossref","first-page":"G1031","DOI":"10.1152\/ajpgi.00211.2011","article-title":"Estrogen deficiency worsens steatohepatitis in mice fed high-fat and high-cholesterol diet","volume":"301","author":"Kamada","year":"2011","journal-title":"Am J Physiol Gastrointest Liver Physiol."},{"issue":"1","key":"2021121718160162400_CIT0054","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3892\/mmr.2016.5236","article-title":"Treatment with estrogen protects against ovariectomy-induced hepatic steatosis by increasing AQP7 expression","volume":"14","author":"Fu","year":"2016","journal-title":"Mol Med Rep."},{"issue":"1","key":"2021121718160162400_CIT0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/molecules23010194","article-title":"Honokiol improves liver steatosis in ovariectomized mice","volume":"23","author":"Jeong","year":"2018","journal-title":"Molecules."},{"issue":"4","key":"2021121718160162400_CIT0056","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1142\/S0192415X13500560","article-title":"Ligusticum chuanxiong prevents ovariectomy-induced liver and vascular damage in rats","volume":"41","author":"Li","year":"2013","journal-title":"Am J Chin Med."},{"issue":"15","key":"2021121718160162400_CIT0057","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.1113\/JP277270","article-title":"Anti-inflammatory effects of oestrogen mediate the sexual dimorphic response to lipid-induced insulin resistance","volume":"597","author":"Camporez","year":"2019","journal-title":"J Physiol."},{"issue":"2","key":"2021121718160162400_CIT0058","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.bbrc.2011.10.025","article-title":"17\u03b2-Estradiol attenuates saturated fatty acid diet-induced liver injury in ovariectomized mice by up-regulating hepatic senescence marker protein-30","volume":"415","author":"Fukui","year":"2011","journal-title":"Biochem Biophys Res Commun."},{"issue":"2","key":"2021121718160162400_CIT0059","doi-asserted-by":"crossref","first-page":"424","DOI":"10.2337\/db11-1718","article-title":"Estrogen treatment after ovariectomy protects against fatty liver and may improve pathway-selective insulin resistance","volume":"62","author":"Zhu","year":"2013","journal-title":"Diabetes."},{"issue":"2","key":"2021121718160162400_CIT0060","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/GME.0000000000000500","article-title":"Surgical menopause and increased risk of nonalcoholic fatty liver disease in endometrial cancer","volume":"23","author":"Matsuo","year":"2016","journal-title":"Menopause."},{"issue":"5","key":"2021121718160162400_CIT0061","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1210\/en.2008-0971","article-title":"Estrogens protect against high-fat diet-induced insulin resistance and glucose intolerance in mice","volume":"150","author":"Riant","year":"2009","journal-title":"Endocrinology."},{"issue":"1","key":"2021121718160162400_CIT0062","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jhep.2015.02.029","article-title":"Hepatic estrogen receptor \u03b1 improves hepatosteatosis through upregulation of small heterodimer partner","volume":"63","author":"Wang","year":"2015","journal-title":"J Hepatol."},{"issue":"12","key":"2021121718160162400_CIT0063","doi-asserted-by":"crossref","first-page":"4098","DOI":"10.2337\/db13-0282","article-title":"Prevention of obesity and insulin resistance by estrogens requires ER\u03b1 activation function-2 (ER\u03b1AF-2), whereas ER\u03b1AF-1 is dispensable","volume":"62","author":"Handgraaf","year":"2013","journal-title":"Diabetes."},{"issue":"3","key":"2021121718160162400_CIT0064","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/BF03401306","article-title":"Sex steroids and sex hormone-binding globulin in postmenopausal women with nonalcoholic fatty liver disease","volume":"12","author":"Polyzos","year":"2013","journal-title":"Hormones (Athens)."},{"issue":"9","key":"2021121718160162400_CIT0065","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1016\/j.cgh.2014.12.033","article-title":"Association between endogenous sex hormones and liver fat in a multiethnic study of atherosclerosis","volume":"13","author":"Lazo","year":"2015","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"1","key":"2021121718160162400_CIT0066","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1365-2265.2006.02543.x","article-title":"Effects of HRT on liver enzyme levels in women with type 2 diabetes: a randomized placebo-controlled trial","volume":"65","author":"McKenzie","year":"2006","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"1","key":"2021121718160162400_CIT0067","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1665-2681(19)31502-9","article-title":"Hormone replacement therapy in menopausal women: risk factor or protection to nonalcoholic fatty liver disease?","volume":"11","author":"Florentino","year":"2012","journal-title":"Ann Hepatol."},{"issue":"3","key":"2021121718160162400_CIT0068","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1590\/S0004-28032013000200032","article-title":"Nonalcoholic fatty liver disease in menopausal women","volume":"50","author":"Florentino","year":"2013","journal-title":"Arq Gastroenterol."},{"key":"2021121718160162400_CIT0069","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/978-3-319-70178-3_12","article-title":"Role of estrogens in the regulation of liver lipid metabolism","volume":"1043","author":"Palmisano","year":"2017","journal-title":"Adv Exp Med Biol."},{"issue":"8319","key":"2021121718160162400_CIT0070","first-page":"257","article-title":"Nolvadex Adjuvant Trial Organisation. Controlled trial of tamoxifen as adjuvant agent in management of early breast cancer. Interim analysis at four years by Nolvadex Adjuvant Trial Organisation","volume":"1","year":"1983","journal-title":"Lancet."},{"issue":"26","key":"2021121718160162400_CIT0071","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1056\/NEJM198812293192601","article-title":"Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women","volume":"319","author":"Early Breast Cancer Trialists\u2019 Collaborative G","year":"1988","journal-title":"N Engl J Med."},{"issue":"3","key":"2021121718160162400_CIT0072","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1053\/sonc.2001.23492","article-title":"Tamoxifen to raloxifene and beyond","volume":"28","author":"O\u2019Regan","year":"2001","journal-title":"Semin Oncol."},{"issue":"1","key":"2021121718160162400_CIT0073","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0168-8278(95)80316-5","article-title":"Tamoxifen-associated steatohepatitis\u2013report of three cases","volume":"23","author":"Pinto","year":"1995","journal-title":"J Hepatol."},{"issue":"3","key":"2021121718160162400_CIT0074","doi-asserted-by":"crossref","first-page":"236","DOI":"10.7326\/0003-4819-123-3-199508010-00018","article-title":"Tamoxifen-induced steatohepatitis","volume":"123","author":"Pratt","year":"1995","journal-title":"Ann Intern Med."},{"issue":"9","key":"2021121718160162400_CIT0075","doi-asserted-by":"crossref","first-page":"855","DOI":"10.7326\/0003-4819-124-9-199605010-00015","article-title":"Tamoxifen-induced steatohepatitis","volume":"124","author":"Van Hoof","year":"1996","journal-title":"Ann Intern Med."},{"issue":"9146","key":"2021121718160162400_CIT0076","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0140-6736(05)74872-8","article-title":"Cirrhosis with steatohepatitis after adjuvant tamoxifen","volume":"353","author":"Oien","year":"1999","journal-title":"Lancet."},{"issue":"9104","key":"2021121718160162400_CIT0077","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S0140-6736(05)78493-2","article-title":"Tamoxifen-induced fatty liver in patients with breast cancer","volume":"351","author":"Ogawa","year":"1998","journal-title":"Lancet."},{"issue":"2","key":"2021121718160162400_CIT0078","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/sj.ijo.0801488","article-title":"Relationships between tamoxifen use, liver fat and body fat distribution in women with breast cancer","volume":"25","author":"Nguyen","year":"2001","journal-title":"Int J Obes Relat Metab Disord."},{"issue":"6","key":"2021121718160162400_CIT0079","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1111\/liv.14434","article-title":"Prevalence, incidence and risk factors of tamoxifen-related non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"40","author":"Lee","year":"2020","journal-title":"Liver Int."},{"issue":"7497","key":"2021121718160162400_CIT0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmj.38391.663287.E0","article-title":"Incidence and risk factors for non-alcoholic steatohepatitis: prospective study of 5408 women enrolled in Italian tamoxifen chemoprevention trial","volume":"330","author":"Bruno","year":"2005","journal-title":"BMJ."},{"issue":"9166","key":"2021121718160162400_CIT0081","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1016\/S0140-6736(05)75907-9","article-title":"Bezafibrate for tamoxifen-induced non-alcoholic steatohepatitis","volume":"353","author":"Saibara","year":"1999","journal-title":"Lancet."},{"issue":"4","key":"2021121718160162400_CIT0082","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1002\/hep.23813","article-title":"Tamoxifen induces triacylglycerol accumulation in the mouse liver by activation of fatty acid synthesis","volume":"52","author":"Cole","year":"2010","journal-title":"Hepatology."},{"issue":"9","key":"2021121718160162400_CIT0083","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1096\/fj.04-3196com","article-title":"Transcript and metabolite analysis of the effects of tamoxifen in rat liver reveals inhibition of fatty acid synthesis in the presence of hepatic steatosis","volume":"19","author":"Lelliott","year":"2005","journal-title":"FASEB J."},{"issue":"6","key":"2021121718160162400_CIT0084","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.ajpath.2017.02.013","article-title":"Selective activation of estrogen receptor \u03b1 activation function-1 is sufficient to prevent obesity, steatosis, and insulin resistance in mouse","volume":"187","author":"Guillaume","year":"2017","journal-title":"Am J Pathol."},{"issue":"7","key":"2021121718160162400_CIT0085","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1002\/hep4.1363","article-title":"Selective liver estrogen receptor \u03b1 modulation prevents steatosis, diabetes, and obesity through the anorectic growth differentiation factor 15 hepatokine in mice","volume":"3","author":"Guillaume","year":"2019","journal-title":"Hepatol Commun."},{"issue":"5","key":"2021121718160162400_CIT0086","doi-asserted-by":"crossref","first-page":"931","DOI":"10.2131\/jts.37.931","article-title":"Hepatoprotective effect of tamoxifen on steatosis and non-alcoholic steatohepatitis in mouse models","volume":"37","author":"Miyashita","year":"2012","journal-title":"J Toxicol Sci."},{"issue":"3-5","key":"2021121718160162400_CIT0087","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jsbmb.2009.01.005","article-title":"Comparing the effects of atamestane, toremifene and tamoxifen alone and in combination, on bone, serum lipids and uterus in ovariectomized rats","volume":"113","author":"Goss","year":"2009","journal-title":"J Steroid Biochem Mol Biol."},{"issue":"1","key":"2021121718160162400_CIT0088","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S8756-3282(96)00313-4","article-title":"Comparative effects of droloxifene, tamoxifen, and estrogen on bone, serum cholesterol, and uterine histology in the ovariectomized rat model","volume":"20","author":"Ke","year":"1997","journal-title":"Bone."},{"key":"2021121718160162400_CIT0089","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.physbeh.2013.05.026","article-title":"Effect of chronic administration of tamoxifen and\/or estradiol on feeding behavior, palatable food and metabolic parameters in ovariectomized rats","volume":"119","author":"Lampert","year":"2013","journal-title":"Physiol Behav."},{"issue":"6","key":"2021121718160162400_CIT0090","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1161\/01.CIR.95.6.1542","article-title":"Tamoxifen decreases cholesterol sevenfold and abolishes lipid lesion development in apolipoprotein E knockout mice","volume":"95","author":"Reckless","year":"1997","journal-title":"Circulation."},{"issue":"9","key":"2021121718160162400_CIT0091","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/ijo.2017.116","article-title":"High-free androgen index is associated with increased risk of non-alcoholic fatty liver disease in women with polycystic ovary syndrome, independent of obesity and insulin resistance","volume":"41","author":"Cai","year":"2017","journal-title":"Int J Obes (Lond)."},{"issue":"11","key":"2021121718160162400_CIT0092","doi-asserted-by":"crossref","first-page":"e0186136","DOI":"10.1371\/journal.pone.0186136","article-title":"Insulin resistance and hyperandrogenism drive steatosis and fibrosis risk in young females with PCOS","volume":"12","author":"Petta","year":"2017","journal-title":"Plos One."},{"issue":"3","key":"2021121718160162400_CIT0093","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/oby.2009.251","article-title":"Testosterone and visceral fat in midlife women: the Study of Women\u2019s Health Across the Nation (SWAN) fat patterning study","volume":"18","author":"Janssen","year":"2010","journal-title":"Obesity (Silver Spring)."},{"issue":"5","key":"2021121718160162400_CIT0094","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/ajg.2017.44","article-title":"Testosterone levels in pre-menopausal women are associated with nonalcoholic fatty liver disease in midlife","volume":"112","author":"Sarkar","year":"2017","journal-title":"Am J Gastroenterol."},{"issue":"11","key":"2021121718160162400_CIT0095","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1111\/liv.13735","article-title":"Serum testosterone and non-alcoholic fatty liver disease in men and women in the US","volume":"38","author":"Yim","year":"2018","journal-title":"Liver Int."},{"issue":"1-2","key":"2021121718160162400_CIT0096","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.bbrc.2015.10.134","article-title":"High fructose consumption induces DNA methylation at PPAR\u03b1 and CPT1A promoter regions in the rat liver","volume":"468","author":"Ohashi","year":"2015","journal-title":"Biochem Biophys Res Commun."},{"issue":"11","key":"2021121718160162400_CIT0097","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1007\/s00018-019-03390-0","article-title":"Fructose-mediated effects on gene expression and epigenetic mechanisms associated with NAFLD pathogenesis","volume":"77","author":"DiStefano","year":"2020","journal-title":"Cell Mol Life Sci."},{"issue":"4","key":"2021121718160162400_CIT0098","doi-asserted-by":"crossref","first-page":"892","DOI":"10.3945\/ajcn.111.020156","article-title":"Choline intake in a large cohort of patients with nonalcoholic fatty liver disease","volume":"95","author":"Guerrerio","year":"2012","journal-title":"Am J Clin Nutr."},{"issue":"10","key":"2021121718160162400_CIT0099","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1096\/fj.07-8227com","article-title":"Phosphatidylethanolamine N-methyltransferase (PEMT) gene expression is induced by estrogen in human and mouse primary hepatocytes","volume":"21","author":"Resseguie","year":"2007","journal-title":"FASEB J."},{"issue":"2","key":"2021121718160162400_CIT0100","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1074\/jbc.M110.106922","article-title":"Aberrant estrogen regulation of PEMT results in choline deficiency-associated liver dysfunction","volume":"286","author":"Resseguie","year":"2011","journal-title":"J Biol Chem."}],"container-title":["Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/endo\/advance-article-pdf\/doi\/10.1210\/endocr\/bqaa134\/33635050\/bqaa134.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/endo\/article-pdf\/161\/10\/bqaa134\/41812323\/bqaa134.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/endo\/article-pdf\/161\/10\/bqaa134\/41812323\/bqaa134.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,17]],"date-time":"2021-12-17T14:39:41Z","timestamp":1639751981000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/endo\/article\/doi\/10.1210\/endocr\/bqaa134\/5890353"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,11]]},"references-count":100,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10,1]]}},"URL":"https:\/\/doi.org\/10.1210\/endocr\/bqaa134","relation":{},"ISSN":["0013-7227","1945-7170"],"issn-type":[{"value":"0013-7227","type":"print"},{"value":"1945-7170","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,10,1]]},"published":{"date-parts":[[2020,8,11]]},"article-number":"bqaa134"}}